EUVIMEDPoznaj EUVIMED
CrossrefKarta informacyjna

Novel nonmagnetic abutment designs for facial prostheses: an experimental study

İREM SOZEN YANİK, UFUK ADALİ, JAMILA YASSINE, FRANSIZKA SCHMIDT, WOLFGANG HANNAK, BAHADIR ERSU

Turkish Journal of Medical Sciences · 2025-02-18 · 55 (1) · 152-160

DOI: 10.55730/1300-0144.5953 ↗
AbstraktDane bibliograficzne

Abstrakt

Background/aim: This in vitro study aimed to evaluate and compare the retentive forces of novel nonmagnetic abutment designs developed as an alternative to conventional magnetic abutments for facial prostheses.Materials and methods: A plexiglass model was constructed and two extraoral implants were placed in these blocks in a parallel position. Nonmagnetic abutments made of titanium were fabricated and screwed onto the implants. The nonmagnetic systems represent a novel design and include two different abutment designs (Type 1 and Type 2) with silicone attachments. Retentive force values for three abutment types: Conventional Magnetic System (CMS), Nonmagnetic abutment Type 1 System (NMS1), and Nonmagnetic abutment Type 2 System (NMS2) were measured at 0th, 120th, 360th, 720th, and 1440th dislodging cycles using a test machine. Given the data's distribution characteristics, non-parametric tests were used for analysis. The Kruskal-Wallis test evaluated significant differences among groups, followed by Dunn's post-hoc test for specific group comparisons. The Friedman test compared the number of dislodging cycles for each group, and the Benjamini-Hochberg adjusted Wilcoxon sign-rank test was used for pairwise comparisons.Results: Both NMS1 and NMS2 groups exhibited significantly higher retentive forces compared to CMS for each of the same dislodging cycles (p

Wiedza dopasowana do Twojej pracy.

Od bezpłatnego startu przez osobiste wyszukiwanie literatury aż po pełny Research Suite.

Zobacz taryfy →

Czy wszystkie pełne teksty wydawców są dostępne?

Nie. Rekordy bibliograficzne, abstrakty i pełne teksty to różne treści. Dostępność zależy od źródła, otwartego dostępu i posiadanych licencji. Plan EUVIMED nie zastępuje dodatkowych praw wydawców.

Zobacz taryfy →